Track the 코미팜 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 코미팜 has logged 37 public disclosures. Market capitalisation: €488.8bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 유경호. All data is accessible without an account.
37
Insider Decl.
n/a
Thresholds
n/a
27 ops.
Buy Volume
n/a
6 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,649 of 29,063 companies
29.7
score / 100
Value
31
Quality
29
FCF yld-1.0%
Earn yld-1.5%
EV/EBITDA·
ROE·
Gross mgn33%
Net mgn-14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.